These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21215647)

  • 1. Epigenetic profiling of the antitumor natural product psammaplin A and its analogues.
    García J; Franci G; Pereira R; Benedetti R; Nebbioso A; Rodríguez-Barrios F; Gronemeyer H; Altucci L; de Lera AR
    Bioorg Med Chem; 2011 Jun; 19(12):3637-49. PubMed ID: 21215647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities.
    Pereira R; Benedetti R; Pérez-Rodríguez S; Nebbioso A; García-Rodríguez J; Carafa V; Stuhldreier M; Conte M; Rodríguez-Barrios F; Stunnenberg HG; Gronemeyer H; Altucci L; de Lera AR
    J Med Chem; 2012 Nov; 55(22):9467-91. PubMed ID: 23030799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
    Baud MG; Leiser T; Haus P; Samlal S; Wong AC; Wood RJ; Petrucci V; Gunaratnam M; Hughes SM; Buluwela L; Turlais F; Neidle S; Meyer-Almes FJ; White AJ; Fuchter MJ
    J Med Chem; 2012 Feb; 55(4):1731-50. PubMed ID: 22280363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents.
    Hong S; Shin Y; Jung M; Ha MW; Park Y; Lee YJ; Shin J; Oh KB; Lee SK; Park HG
    Eur J Med Chem; 2015; 96():218-30. PubMed ID: 25884112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues.
    Souto JA; Vaz E; Lepore I; Pöppler AC; Franci G; Alvarez R; Altucci L; de Lera AR
    J Med Chem; 2010 Jun; 53(12):4654-67. PubMed ID: 20491440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation.
    Jiang Y; Tang Y; Li Y; Liu L; Yue K; Li X; Qiu P; Yin R; Jiang T
    Eur J Med Chem; 2024 Sep; 275():116541. PubMed ID: 38851056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispyridinium dienes: histone deacetylase inhibitors with selective activities.
    Pérez-Balado C; Nebbioso A; Rodríguez-Graña P; Minichiello A; Miceli M; Altucci L; de Lera AR
    J Med Chem; 2007 May; 50(10):2497-505. PubMed ID: 17447750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.
    Mai A; Massa S; Rotili D; Simeoni S; Ragno R; Botta G; Nebbioso A; Miceli M; Altucci L; Brosch G
    J Med Chem; 2006 Oct; 49(20):6046-56. PubMed ID: 17004718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity.
    Mai A; Valente S; Rotili D; Massa S; Botta G; Brosch G; Miceli M; Nebbioso A; Altucci L
    Int J Biochem Cell Biol; 2007; 39(7-8):1510-22. PubMed ID: 17482499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.
    Su H; Nebbioso A; Carafa V; Chen Y; Yang B; Altucci L; You Q
    Bioorg Med Chem; 2008 Sep; 16(17):7992-8002. PubMed ID: 18701301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.
    Trisciuoglio D; Ragazzoni Y; Pelosi A; Desideri M; Carradori S; Gabellini C; Maresca G; Nescatelli R; Secci D; Bolasco A; Bizzarri B; Cavaliere C; D'Agnano I; Filetici P; Ricci-Vitiani L; Rizzo MG; Del Bufalo D
    Clin Cancer Res; 2012 Jan; 18(2):475-86. PubMed ID: 22068659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity.
    Hentschel F; Sasse F; Lindel T
    Org Biomol Chem; 2012 Sep; 10(35):7120-33. PubMed ID: 22872318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
    Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
    J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of curcumin on acetylation of histone H3 in human lymphoma cell line Raji].
    Li XG; Chen Y; Wu Q; Sun CY
    Ai Zheng; 2006 May; 25(5):582-6. PubMed ID: 16687078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents.
    Wen J; Bao Y; Niu Q; Liu J; Yang J; Wang W; Jiang T; Fan Y; Li K; Wang J; Zhao L; Liu D
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4372-6. PubMed ID: 27460171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
    Suzuki T; Nagano Y; Kouketsu A; Matsuura A; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
    J Med Chem; 2005 Feb; 48(4):1019-32. PubMed ID: 15715470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine-Derived Natural Lead Compound Disulfide-Linked Dimer Psammaplin A: Biological Activity and Structural Modification.
    Jing Q; Hu X; Ma Y; Mu J; Liu W; Xu F; Li Z; Bai J; Hua H; Li D
    Mar Drugs; 2019 Jun; 17(7):. PubMed ID: 31252563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved synthesis of psammaplin A.
    Godert AM; Angelino N; Woloszynska-Read A; Morey SR; James SR; Karpf AR; Sufrin JR
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3330-3. PubMed ID: 16632351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisynthetic maytansine analogues for the targeted treatment of cancer.
    Widdison WC; Wilhelm SD; Cavanagh EE; Whiteman KR; Leece BA; Kovtun Y; Goldmacher VS; Xie H; Steeves RM; Lutz RJ; Zhao R; Wang L; Blättler WA; Chari RV
    J Med Chem; 2006 Jul; 49(14):4392-408. PubMed ID: 16821799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.